BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1120 related articles for article (PubMed ID: 32717056)

  • 1. Head-to-Head Comparison of Two SARS-CoV-2 Serology Assays.
    Merrill AE; Jackson JB; Ehlers A; Voss D; Krasowski MD
    J Appl Lab Med; 2020 Nov; 5(6):1351-1357. PubMed ID: 32717056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-Platform Comparison of SARS-CoV-2 Serology Assays for the Detection of COVID-19.
    Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL
    J Appl Lab Med; 2020 Nov; 5(6):1324-1336. PubMed ID: 32766840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of an Electrochemiluminescent SARS-CoV-2 Antibody Assay.
    Lau CS; Hoo SP; Yew SF; Ong SK; Lum LT; Heng PY; Tan JG; Wong MS; Aw TC
    J Appl Lab Med; 2020 Nov; 5(6):1313-1323. PubMed ID: 32717060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-Comparison of a Chemiluminescent Platform and a Commercial Receptor Binding Domain-Based ELISA for Detecting SARS-CoV-2 IgG.
    Antoine-Reid T; Malone J; Maris AS; White-Abell J; Schmitz JE
    J Appl Lab Med; 2020 Nov; 5(6):1416-1420. PubMed ID: 32750140
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis.
    Liu R; Liu X; Yuan L; Han H; Shereen MA; Zhen J; Niu Z; Li D; Liu F; Wu K; Luo Z; Zhu C
    Int Immunopharmacol; 2020 Sep; 86():106746. PubMed ID: 32619956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Side-by-Side Comparison of Three Fully Automated SARS-CoV-2 Antibody Assays with a Focus on Specificity.
    Perkmann T; Perkmann-Nagele N; Breyer MK; Breyer-Kohansal R; Burghuber OC; Hartl S; Aletaha D; Sieghart D; Quehenberger P; Marculescu R; Mucher P; Strassl R; Wagner OF; Binder CJ; Haslacher H
    Clin Chem; 2020 Nov; 66(11):1405-1413. PubMed ID: 32777031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of SARS-CoV-2 IgG antibody response in PCR positive patients: Comparison of nine tests in relation to clinical data.
    Naaber P; Hunt K; Pesukova J; Haljasmägi L; Rumm P; Peterson P; Hololejenko J; Eero I; Jõgi P; Toompere K; Sepp E
    PLoS One; 2020; 15(10):e0237548. PubMed ID: 33108380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of COVID-19 convalescent plasma for SARS-CoV-2 IgG using two commercial immunoassays.
    DomBourian MG; Annen K; Huey L; Andersen G; Merkel PA; Jung S; Dominguez SR; Knight V
    J Immunol Methods; 2020 Nov; 486():112837. PubMed ID: 32828791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Six Commercial Mid- to High-Volume Antibody and Six Point-of-Care Lateral Flow Assays for Detection of SARS-CoV-2 Antibodies.
    Charlton CL; Kanji JN; Johal K; Bailey A; Plitt SS; MacDonald C; Kunst A; Buss E; Burnes LE; Fonseca K; Berenger BM; Schnabl K; Hu J; Stokes W; Zelyas N; Tipples G
    J Clin Microbiol; 2020 Sep; 58(10):. PubMed ID: 32665420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and Analytical Performance of an Automated Serological Test That Identifies S1/S2-Neutralizing IgG in COVID-19 Patients Semiquantitatively.
    Bonelli F; Sarasini A; Zierold C; Calleri M; Bonetti A; Vismara C; Blocki FA; Pallavicini L; Chinali A; Campisi D; Percivalle E; DiNapoli AP; Perno CF; Baldanti F
    J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32580948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip.
    Prazuck T; Colin M; Giachè S; Gubavu C; Seve A; Rzepecki V; Chevereau-Choquet M; Kiani C; Rodot V; Lionnet E; Courtellemont L; Guinard J; Pialoux G; Hocqueloux L
    PLoS One; 2020; 15(9):e0237694. PubMed ID: 32941461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid Serological Assays and SARS-CoV-2 Real-Time Polymerase Chain Reaction Assays for the Detection of SARS-CoV-2: Comparative Study.
    Paradiso AV; De Summa S; Loconsole D; Procacci V; Sallustio A; Centrone F; Silvestris N; Cafagna V; De Palma G; Tufaro A; Garrisi VM; Chironna M
    J Med Internet Res; 2020 Oct; 22(10):e19152. PubMed ID: 33031048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of five different automated SARS-CoV-2 serology assays in a cohort of hospitalized COVID-19 patients.
    Pflüger LS; Bannasch JH; Brehm TT; Pfefferle S; Hoffmann A; Nörz D; van der Meirschen M; Kluge S; Haddad M; Pischke S; Hiller J; Addo MM; Lohse AW; Schulze Zur Wiesch J; Peine S; Aepfelbacher M; Lütgehetmann M
    J Clin Virol; 2020 Sep; 130():104549. PubMed ID: 32763809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation.
    Jääskeläinen AJ; Kuivanen S; Kekäläinen E; Ahava MJ; Loginov R; Kallio-Kokko H; Vapalahti O; Jarva H; Kurkela S; Lappalainen M
    J Clin Virol; 2020 Aug; 129():104512. PubMed ID: 32563180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies.
    Boukli N; Le Mene M; Schnuriger A; Cuervo NS; Laroche C; Morand-Joubert L; Gozlan J
    J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32848041
    [No Abstract]   [Full Text] [Related]  

  • 16. Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays.
    Wolff F; Dahma H; Duterme C; Van den Wijngaert S; Vandenberg O; Cotton F; Montesinos I
    Diagn Microbiol Infect Dis; 2020 Nov; 98(3):115140. PubMed ID: 32829098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid Determination of SARS-CoV-2 antibodies using a bedside, point-of-Care, serological test.
    Dortet L; Emeraud C; Vauloup-Fellous C; Khecharem M; Ronat JB; Fortineau N; Roque-Afonso AM; Naas T
    Emerg Microbes Infect; 2020 Dec; 9(1):2212-2221. PubMed ID: 32969769
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative evaluation of SARS-CoV-2 IgG assays in India.
    Chaudhuri S; Thiruvengadam R; Chattopadhyay S; Mehdi F; Kshetrapal P; Shrivastava T; Desiraju BK; Batra G; Kang G; Bhatnagar S;
    J Clin Virol; 2020 Oct; 131():104609. PubMed ID: 32866811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal Monitoring of SARS-CoV-2 IgM and IgG Seropositivity to Detect COVID-19.
    Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL
    J Appl Lab Med; 2020 Sep; 5(5):908-920. PubMed ID: 32428207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.